<List><item><source>MED</source><extId>25517315</extId><pmcid>PMC4622538</pmcid><annotations><annotation><prefix>1/2 clinical trials </prefix><exact>NCT00949988</exact><postfix> and NCT01173679, re</postfix><tags><tag><name>NCT00949988</name><uri>http://identifiers.org/clinicaltrials/NCT00949988</uri></tag></tags><id>http://europepmc.org/articles/PMC4622538#europepmc-a622391daea92b8e409de5bf42245329</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>trials NCT00949988 and </prefix><exact>NCT01173679</exact><postfix>, respectively). </postfix><tags><tag><name>NCT01173679</name><uri>http://identifiers.org/clinicaltrials/NCT01173679</uri></tag></tags><id>http://europepmc.org/articles/PMC4622538#europepmc-83bfce2ad7aacac14437eb7131dc365c</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>sible via GEO Series accession number </prefix><exact>GSE50929</exact><postfix>. </postfix><tags><tag><name>GSE50929</name><uri>http://identifiers.org/geo/GSE50929</uri></tag></tags><id>http://europepmc.org/articles/PMC4622538#europepmc-a74021706b2f17de1d6ba78fe0acc687</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>GEO</subType></annotation><annotation><prefix>sible via GEO Series accession number </prefix><exact>GSE50929</exact><postfix>. </postfix><tags><tag><name>GSE50929</name><uri>http://identifiers.org/geo/GSE50929</uri></tag></tags><id>http://europepmc.org/articles/PMC4622538#europepmc-a74021706b2f17de1d6ba78fe0acc687</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>GEO</subType></annotation></annotations></item></List>